These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6259606

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB, Canton P, Roche G, Weber M, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):601-6. PubMed ID: 6259602
    [Abstract] [Full Text] [Related]

  • 3. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N, van Laethem Y, Vanhoof R, George C, Rapin M, Butzler JP.
    Scand J Infect Dis; 1982 Feb 26; 14(1):57-60. PubMed ID: 6280269
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J, Acar JF, Justin C, Kitzis MD.
    Nouv Presse Med; 1981 Feb 26; 10(8):625-7. PubMed ID: 6259607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
    Goulon M, Gajdos P, Pilliot J.
    Nouv Presse Med; 1981 Feb 26; 10(8):613-6. PubMed ID: 6259604
    [Abstract] [Full Text] [Related]

  • 10. [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
    Aufrant C, Lambert-Zechovsky N, Aujard Y, Bingen E, Blum C, Beaufils F, Mathieu H.
    Nouv Presse Med; 1981 Feb 26; 10(8):639-46. PubMed ID: 6259610
    [Abstract] [Full Text] [Related]

  • 11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E, 309 Study Group.
    J Antimicrob Chemother; 2008 Sep 26; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [Abstract] [Full Text] [Related]

  • 12. [Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
    Bastin R, Frottier J, Vilde JL, Bure A.
    Nouv Presse Med; 1981 Feb 26; 10(8):598-600. PubMed ID: 6259601
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM, Giraud F.
    Nouv Presse Med; 1981 Feb 26; 10(8):629-33. PubMed ID: 6259608
    [Abstract] [Full Text] [Related]

  • 16. [Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
    Motin J, Bouletreau P, Auboyer C, Bui-Xuan B, Flandrois JP, Reverdy ME.
    Nouv Presse Med; 1981 Feb 26; 10(8):617-21. PubMed ID: 6259605
    [No Abstract] [Full Text] [Related]

  • 17. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE, Neu HC.
    Am J Surg; 1984 Oct 19; 148(4A):35-40. PubMed ID: 6091479
    [Abstract] [Full Text] [Related]

  • 18. Third-generation cephalosporins: a critical evaluation.
    Barriere SL, Flaherty JF.
    Clin Pharm; 1984 Oct 19; 3(4):351-73. PubMed ID: 6432420
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
    Arich C, Gouby A, Bengler C, Ardilouze JL, Dubois A, Joubert P, Hansel S, Janbon C, Fabre S.
    Pathol Biol (Paris); 1987 May 19; 35(5):613-5. PubMed ID: 3302868
    [Abstract] [Full Text] [Related]

  • 20. [Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)].
    Poletti T, Bertola D, Pellerito R, Soragna A.
    Minerva Med; 1980 Jul 19; 71(27):1935-43. PubMed ID: 6248823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.